Belgian heart patients tracked on new cholesterol drug
NCT ID NCT05726838
Summary
This study is observing 600 Belgian patients with heart disease who are taking the cholesterol-lowering injection inclisiran along with their standard medications. Researchers are tracking how well the drug lowers 'bad' cholesterol (LDL-C) in real-world doctor's offices, not a controlled trial. The goal is to understand how effective and safe the treatment is when used in everyday medical practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Turnhout, Antwerpen, 2300, Belgium
-
Novartis Investigative Site
Genk, Limburg, 3600, Belgium
-
Novartis Investigative Site
Yvoir, Namur, 5530, Belgium
-
Novartis Investigative Site
Leuven, Vlaams Brabant, 3000, Belgium
-
Novartis Investigative Site
Kortrijk, West-Vlaanderen, 8500, Belgium
-
Novartis Investigative Site
Aalst, 9300, Belgium
-
Novartis Investigative Site
Anderlecht, 1070, Belgium
-
Novartis Investigative Site
Brasschaat, 2930, Belgium
-
Novartis Investigative Site
Brussels, 1020, Belgium
-
Novartis Investigative Site
Edegem, 2650, Belgium
-
Novartis Investigative Site
Ghent, 9000, Belgium
-
Novartis Investigative Site
Haine-Saint-Paul, 7100, Belgium
-
Novartis Investigative Site
Huy, 4500, Belgium
-
Novartis Investigative Site
Liège, 4000, Belgium
-
Novartis Investigative Site
Mechelen, 2800, Belgium
Conditions
Explore the condition pages connected to this study.